An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Reh, Juliane ^a,b   Stange, Annett ^a,b   Götz, Anne ^a,b   Rönitz, Marlene ^a,b   Große, Arend ^a,b   Lindemann, Dirk ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Budding; Foamy virus; Helical motif; Protein protein Interaction

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SPUMA VIRUS; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SPUMAVIRUS; VIRULENCE; VIRUS ATTACHMENT; VIRUS RELEASE;

HUMAN SPUMARETROVIRUS; MAMMALIA; MIRIDAE; PROKARYOTA;

EID: 84876993949     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-45     Document Type: Article

References (34)

1. Johnson MC. Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res Hum Retroviruses 2011, 27:239-247. 10.1089/aid.2010.0350, 3048835, 21247353.
2. Tobaly-Tapiero J, Bittoun P, Neves M, Guillemin MC, Lecellier CH, Puvion-Dutilleul F, Gicquel B, Zientara S, Giron ML, de The H, Saib A. Isolation and characterization of an equine foamy virus. J Virol 2000, 74:4064-4073. 10.1128/JVI.74.9.4064-4073.2000, 111920, 10756018.
3. Pietschmann T, Heinkelein M, Heldmann M, Zentgraf H, Rethwilm A, Lindemann D. Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999, 73:2613-2621. 104016, 10074106.
4. Morozov VA, Copeland TD, Nagashima K, Gonda MA, Oroszlan S. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology 1997, 228:307-317. 10.1006/viro.1996.8379, 9123838.
5. Sun Y, Wen DD, Liu QM, Yi XF, Wang TT, Wei LL, Li Z, Liu WH, He XH. Comparative analysis of the envelope glycoproteins of foamy viruses. Acta Virol 2012, 56:283-291. 10.4149/av_2012_04_283, 23237084.
6. Wang G, Mulligan MJ. Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J Gen Virol 1999, 80:245-254.
7. Goepfert PA, Wang G, Mulligan MJ. Identification of an ER retrieval signal in a retroviral glycoprotein. Cell 1995, 82:543-544. 10.1016/0092-8674(95)90026-8, 7664333.
8. Swiersy A, Wiek C, Reh J, Zentgraf H, Lindemann D. Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication. Retrovirology 2011, 8:66. 10.1186/1742-4690-8-66, 3196705, 21843316.
9. Lindemann D, Rethwilm A. Foamy virus biology and its application for vector development. Viruses 2011, 3:561-585. 10.3390/v3050561, 3185757, 21994746.
10. Baldwin DN, Linial ML. The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol 1998, 72:3658-3665. 109586, 9557646.
11. Fischer N, Heinkelein M, Lindemann D, Enssle J, Baum C, Werder E, Zentgraf H, Müller JG, Rethwilm A. Foamy virus particle formation. J Virol 1998, 72:1610-1615. 124643, 9445065.
12. Yu SF, Eastman SW, Linial ML. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 2006, 7:966-977. 10.1111/j.1600-0854.2006.00448.x, 16749903.
13. Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, Thurow J, Knaus P, Zentgraf H, Rethwilm A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 2001, 75:5762-5771. 10.1128/JVI.75.13.5762-5771.2001, 114292, 11390578.
14. Wilk T, Geiselhart V, Frech M, Fuller SD, Flugel RM, Lochelt M. Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol 2001, 75:7995-8007. 10.1128/JVI.75.17.7995-8007.2001, 115043, 11483744.
15. Duda A, Stange A, Luftenegger D, Stanke N, Westphal D, Pietschmann T, Eastman SW, Linial ML, Rethwilm A, Lindemann D. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol 2004, 78:13865-13870. 10.1128/JVI.78.24.13865-13870.2004, 533949, 15564494.
16. Geiselhart V, Bastone P, Kempf T, Schnolzer M, Löchelt M. Furin-mediated cleavage of the feline foamy virus Env leader protein. J Virol 2004, 78:13573-13581. 10.1128/JVI.78.24.13573-13581.2004, 533928, 15564468.
17. Flügel RM, Pfrepper KI. Proteolytic processing of foamy virus Gag and Pol proteins. Curr Top Microbiol Immunol 2003, 277:63-88. 10.1007/978-3-642-55701-9_3, 12908768.
18. Tobaly-Tapiero J, Bittoun P, Giron ML, Neves M, Koken M, Saib A, de The H. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol 2001, 75:4367-4375. 10.1128/JVI.75.9.4367-4375.2001, 114181, 11287585.
19. Petit C, Giron ML, Tobaly-Tapiero J, Bittoun P, Real E, Jacob Y, Tordo N, De The H, Saib A. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J Cell Sci 2003, 116:3433-3442. 10.1242/jcs.00613, 12857789.
20. Cartellieri M, Herchenröder O, Rudolph W, Heinkelein M, Lindemann D, Zentgraf H, Rethwilm A. N-terminal gag domain required for foamy virus particle assembly and export. J Virol 2005, 79:12464-12476. 10.1128/JVI.79.19.12464-12476.2005, 1211529, 16160174.
21. Geiselhart V, Schwantes A, Bastone P, Frech M, Löchelt M. Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology 2003, 310:235-244. 10.1016/S0042-6822(03)00125-9, 12781711.
22. Life RB, Lee EG, Eastman SW, Linial ML. Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly. J Virol 2008, 82:6109-6119. 10.1128/JVI.00503-08, 2447090, 18434404.
23. Stange A, Mannigel I, Peters K, Heinkelein M, Stanke N, Cartellieri M, Göttlinger H, Rethwilm A, Zentgraf H, Lindemann D. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol 2005, 79:5466-5476. 10.1128/JVI.79.9.5466-5476.2005, 1082757, 15827161.
24. Stirnnagel K, Luftenegger D, Stange A, Swiersy A, Mullers E, Reh J, Stanke N, Grosse A, Chiantia S, Keller H. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 2010, 7:45. 10.1186/1742-4690-7-45, 2887381, 20478027.
25. Eastman SW, Linial ML. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol 2001, 75:6857-6864. 10.1128/JVI.75.15.6857-6864.2001, 114413, 11435565.
26. Goldstone DC, Flower TG, Ball NJ, Sanz-Ramos M, Yap MW, Ogrodowicz RW, Stanke N, Reh J, Lindemann D, Stoye JP, Taylor IA. A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral Matrix and Capsid. PLoS Pathog 2013, 9:e1003376. 10.1371/journal.ppat.1003376, 3649970, 23675305.
27. Pietschmann T, Zentgraf H, Rethwilm A, Lindemann D. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol 2000, 74:4474-4482. 10.1128/JVI.74.10.4474-4482.2000, 111968, 10775583.
28. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987, 7:379-387. 365079, 3031469.
29. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 1974, 33:1027-1033. 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z, 4132053.
30. Heinkelein M, Dressler M, Jarmy G, Rammling M, Imrich H, Thurow J, Lindemann D, Rethwilm A. Improved primate foamy virus vectors and packaging constructs. J Virol 2002, 76:3774-3783. 10.1128/JVI.76.8.3774-3783.2002, 136074, 11907217.
31. Lindemann D, Bock M, Schweizer M, Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol 1997, 71:4815-4820. 191705, 9151877.
32. Ho YP, Schnabel V, Swiersy A, Stirnnagel K, Lindemann D. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors. Mol Ther 2012, 20:1167-1176. 10.1038/mt.2012.61, 22472951.
33. Mannigel I, Stange A, Zentgraf H, Lindemann D. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 2007, 81:3317-3326. 10.1128/JVI.01866-06, 1866044, 17229703.
34. Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science 1991, 252:1162-1164. 10.1126/science.252.5009.1162, 2031185.